HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bis(aspirinato)zinc(II)

has cardioprotective and antidiabetic activities

Also Known As:

Zn(asp)2

Networked: 7 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Hydroxybenzoates: 18
        Salicylates: 2339
        Aspirin: 29782
        bis(aspirinato)zinc(II): 7
- Coordination Complexes: 576
  - bis(aspirinato)zinc(II): 7
Inorganic Chemicals: 9
- Coordination Complexes: 576
  - bis(aspirinato)zinc(II): 7

Experts

1.	Yasui, Hiroyuki: 5 articles (05/2016 - 01/2011)
2.	Yoshikawa, Yutaka: 5 articles (05/2016 - 01/2011)
3.	Karck, Matthias: 4 articles (05/2016 - 12/2014)
4.	Li, Shiliang: 4 articles (05/2016 - 12/2014)
5.	Radovits, Tamás: 4 articles (05/2016 - 12/2014)
6.	Szabó, Gábor: 4 articles (05/2016 - 12/2014)
7.	Atmanli, Ayhan: 3 articles (05/2016 - 09/2015)
8.	Brlecic, Paige: 2 articles (05/2016 - 03/2016)
9.	Hegedűs, Péter: 2 articles (05/2016 - 12/2014)
10.	Korkmaz-Icöz, Sevil: 2 articles (05/2016 - 03/2016)

Related Diseases

1.	Myocardial Ischemia (Ischemic Heart Diseases) 09/01/2015 - "In conclusion, our data demonstrate that oral administration of zinc and ASA in the form of bis(aspirinato)zinc(II) complex is superior to ASA in preventing electrical, mechanical, and histological changes after acute myocardial ischemia. " 03/01/2016 - "We recently demonstrated that the pre-treatment of rats with zinc and acetylsalicylic acid complex in the form of bis(aspirinato)zinc(II) [Zn(ASA)2] is superior to acetylsalicylic acid in protecting the heart from acute myocardial ischemia. "
2.	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/01/2011 - "Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes."
3.	Hyperglycemia 01/01/2011 - "Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes."
4.	Infections 01/01/2000 - "Former studies showed that complexes of Zn(II) with picolinic and with aspartic acids, Zn(pic)(2) and Zn(asp)(2), are able to inhibit HSV infection in cultured cells by affecting key steps of virus replication. " 02/01/1993 - "The influence of Zn-complexes with biologically active ligands like aminoacids: picolinic acid as Zn(pic)2 and asparaginic acid as Zn(asp)2 on HSV-1 infection in vitro was investigated. "
5.	Neointima 12/01/2014 - "This study examines the effect of the novel bis (aspirinato) zinc (II) complex on neointima formation in a rat model of carotid balloon-injury. " 12/01/2014 - "Bis (aspirinato) zinc (II) complex successfully inhibits carotid arterial neointima formation after balloon-injury in rats."

Related Drugs and Biologics

1.	Zinc
2.	Aspirin (Acetylsalicylic Acid)
3.	Salicylates
4.	Acids
5.	Ligands
6.	picolinic acid (chromium picolinate)

Related Therapies and Procedures

1.	Oral Administration